Sonas Pharma has closed a pre-seed funding round backed by SFC Capital and Clarendon Fund Managers...
Category - Pharmaceuticals
Interim Phase 2 data show functional improvement with IMM01-STEM...
Immunis has reported interim Phase 2 clinical data showing improvements in physical function among...
Novartis ianalumab receives FDA Breakthrough Therapy designation...
Novartis has received US Food and Drug Administration Breakthrough Therapy designation for...
Jasper Therapeutics reports positive briquilimab data in chronic...
Jasper Therapeutics has reported updated clinical data showing disease control in patients treated...
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...
Sanofi to acquire Dynavax, expanding adult vaccine portfolio
Sanofi has agreed to acquire Dynavax Technologies Corporation, adding an approved adult hepatitis B...
GSK Announces Promising Blood Cancer Data at ASH 2025 –...
GSK is set to present new data from its haematology portfolio at the American Society of Hematology...